Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

9.590 +0.140 (+1.48%)
Official Closing Price Updated: 7:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,591,028
Open 9.610
Bid (Size) 9.560 (9)
Ask (Size) 9.570 (9)
Prev. Close 9.450
Today's Range 9.180 - 9.750
52wk Range 9.180 - 23.10
Shares Outstanding N/A
Dividend Yield 11.68%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists
Organon shares sank 27% Thursday after slashing its dividend by over 90%, triggering analyst downgrades and investor concern. Some retail traders, however, remained upbeat, citing the company’s focus... 
Via Stocktwits
Topics World Trade
Exposures Tariff
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill

Performance

YTD
-35.9%
-35.9%
1 Month
-26.5%
-26.5%
3 Month
-35.7%
-35.7%
6 Month
-43.3%
-43.3%
1 Year
-53.6%
-53.6%

More News

Read More
Organon & Co. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OGN
From DJS Law Group
Via Business Wire
Earnings Scheduled For May 1, 2025
Via Benzinga
OGN Investors Have Opportunity to Join Organon & Co. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Top stock movements in today's session.
Via Chartmill
Dow Surges Over 300 Points; McDonald's Posts Weak Revenue
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
These stocks are moving in today's pre-market session
Via Chartmill
Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q1 But Stock Drops 23.5%
Via StockStory
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Organon Reports Results for the First Quarter Ended March 31, 2025
From Organon & Co.
Via Business Wire
Organon (OGN) Q1 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Tariff
3 Cash-Producing Stocks with Questionable Fundamentals
Via StockStory
LGI Homes, Super Micro, Organon, Ibotta, and ManpowerGroup Stocks Trade Up, What You Need To Know
Via StockStory
Topics World Trade
Exposures Tariff
Organon Appoints Ramona A. Sequeira to the Company’s Board of Directors
From Organon & Co.
Via Business Wire
Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025
From Organon & Co.
Via Business Wire
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Organon (OGN): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.
From Organon & Co.
Via Business Wire
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
From Organon & Co.
Via Business Wire
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
3 Small-Cap Stocks Skating on Thin Ice
Via StockStory

Frequently Asked Questions

Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 9.590
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 05/02/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.